Pharmacogenomics Knowledge Base, PharmGKB (R24)

The summary for the Pharmacogenomics Knowledge Base, PharmGKB (R24) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pharmacogenomics Knowledge Base, PharmGKB (R24): Purpose. The purpose of this funding opportunity issued by NIGMS is to enable new and renewal applications to compete for the Pharmacogenetics and Pharmacogenomics Knowledge Base, PharmGKB (, which will be renamed the Pharmacogenomics Knowledge Base. PharmGKB is being developed to serve the needs of the entire research community in pharmacogenomics. Optimally, the knowledge base PharmGKB will present complete, comprehensive, and current knowledge in pharmacogenomics, backed by the critical datasets (which may be archived elsewhere) and the most compelling literature. There are informatics challenges to managing and integrating large and disparate sets of information, and a compelling resource should be easily used and extremely valuable to stakeholders trying to advance the field of pharmacogenomics and its implementation. The ultimate goal of pharmacogenomics is to guide appropriate therapeutic choices, and PharmGKB should support and extend modern research approaches to achieve this goal. Previously, PharmGKB was a component of the Pharmacogenetics Research Network; now the network is the subject of another funding opportunity announcement (Pharmacogenomics Research Network, RFA-GM-10-001, PharmGKB is being renewed separately as a R24 in order to enable the knowledge base to be developed to clearly serve the needs of the entire research community in pharmacogenomics.
Federal Grant Title: Pharmacogenomics Knowledge Base, PharmGKB (R24)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-GM-10-002
Type of Funding: Grant
CFDA Numbers: 93.859
CFDA Descriptions: Biomedical Research and Research Training
Current Application Deadline: Jun 02, 2009
Original Application Deadline: Jun 02, 2009
Posted Date: Mar 05, 2009
Creation Date: Mar 05, 2009
Archive Date: Jul 03, 2009
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Innovative Programs to Enhance Research Training (IPERT) (R25 - Independent Clinical Trial...
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent ...
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoct...
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institut...
Tools for Genetic and Genomic Studies in Emerging Model Organisms
Evolution of Infectious Diseases
Mbrs Support of Continuous Research Excellence (Score)
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020